insights_auto
Why is SABS down 3,90%?
Dive Deeperchevron_right
SABS:NASDAQ
SAB Biotherapeutics Inc
2,96 $
arrow_downward
-3,90%(-0,12) 1D
13 նոյ, 16:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SABS...
Open
3,08 $
High
3,15 $
Low
2,85 $
Mkt. cap
266,66 մլն
Avg. vol.
700,24 հզր
Volume
658,12 հզր
52-wk high
5,15 $
52-wk low
2,44 $
EPS
-0,93 $
Beta
0,67
Shares outstanding
90,09 մլն
No. of employees
86
Open
3,08 $
High
3,15 $
Low
2,85 $
Mkt. cap
266,66 մլն
Avg. vol.
700,24 հզր
Volume
658,12 հզր
52-wk high
5,15 $
52-wk low
2,44 $
EPS
-0,93 $
Beta
0,67
Shares outstanding
90,09 մլն
No. of employees
86
News stories
From web sources and news partners
BigGo Finance
·
59 րոպե առաջ
Goldman Sachs Sets 8,700 S&P 500 Target for 2027, Sees 14% Upside as AI Capex Peaks
TradingKey
·
11 ժամ առաջ
S&P 500 Forecast: Index Poised to Retest Record High in November After 500-Point Pullback, Biggest Daily Gain in Nearly Seven Months
The Motley Fool
·
22 ժամ առաջ
Prediction: This Small-Cap Value ETF Will Beat the S&P 500 Over the Next 10 Years
StoneX
·
2 օր առաջ
S&P 500, Nasdaq 100 Claw Back But NVDA Cloud Looms Overhead
About SAB Biotherapeutics Inc
CEO-
Employees86
Founded2014
HeadquartersՄայամի Բիչ, Ֆլորիդա, Միացյալ Նահանգներ
SectorHealth Care
Industry-
Websitesab.bio